Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β Smad Signaling. Rev Diabet Stud 2026, 62-76. https://doi.org/10.70082/y1zx3j95.